Low-dose metronomic chemotherapy as an efficient treatment option in metastatic breast cancer-results of an exploratory case-control study.

Breast Cancer Res Treat · 2020 · PMC7297707 · PMID 32495001

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

borderline significanceno p-value reported

However, among triple-negative patients, 30.0% patients with LDMC compared to 5.0% patients with CCT showed DCR ( p = 0.095) resulting in a borderline significance in favor of LDMC.

also in 7,017 other papers

a trend towards significanceno p-value reported

12.0 weeks ( p = 0.064) with a trend towards significance.

also in 2,760 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.